Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Lee

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
ESMO Open|October 9, 2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancerD Tai, T Conroy, J J X Lee, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registryBruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.
Immunity|May 30, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
The Lancet. Oncology|August 28, 2020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyLennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, et al.
Cancers|July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in EuropeDavid J Pinato, Alvin J X Lee, Federica Biello, et al.
Immunity|April 25, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Blood|August 28, 2014
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysisAdam M Petrich, Mitul Gandhi, Borko Jovanovic, et al.
Therapeutic Advances in Medical Oncology|September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspectiveGehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
The Lancet. Oncology|May 26, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control studyLennard Y W Lee, Thomas Starkey, Maria C Ionescu, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Nature Communications|March 13, 2019
Author Correction: Loss of Phd2 cooperates with BRAF<sup>V600E</sup> to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.
ESMO Open|October 9, 2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancerD Tai, T Conroy, J J X Lee, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registryBruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.
Immunity|May 30, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
The Lancet. Oncology|August 28, 2020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyLennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, et al.
Cancers|July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in EuropeDavid J Pinato, Alvin J X Lee, Federica Biello, et al.
Immunity|April 25, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.
Blood|August 28, 2014
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysisAdam M Petrich, Mitul Gandhi, Borko Jovanovic, et al.
Therapeutic Advances in Medical Oncology|September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspectiveGehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
The Lancet. Oncology|May 26, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control studyLennard Y W Lee, Thomas Starkey, Maria C Ionescu, et al.
Pageof 23